External assurance
Below is a list of some of the externally generated assurance mechanisms in place that can add assurance and thereby credibility to the company’s activities and reporting with regard to accuracy, completeness and reliability for different stakeholders.
Externally generated assurance mechanisms:
- Financial audits of annual financial results
- Assurance of annual non-financial results
- Share price
- FDA requirements and control in relation to products and production
- Regulatory approvals
- Benchmarks, ratings and surveys, eg Global Reporters 2006
- SRI ratings, eg SAM, oekom, EIRIS, SIRI and others
- Inclusion in SRI indices, eg Dow Jones and FTSE4Good
- Community Growth Funds, eg World Diabetes Foundation
- Other requirements and control by authorities
- External audits as part of ISO 9001 and ISO 14001 certification
- Annual Report (including non-financial information and other reporting formats, eg Annual Review and online version of the report)
- Quarterly Financial Statements
- Press releases
- Financial results presentations, eg roadshows
- Specialist publications, eg Novo Nordisk’s stakeholder magazine Share
- Websites, eg Diabetes, DAWN, Equal Opportunities toolbox, Supplier Toolbox
- Internet
- Helplines.
Strategies, policies and programmes add assurance by means of:
- Investor Relations Programmes
- Public policies and positions, eg animal welfare policies
- Procurement policies
- Advertising and marketing in accordance with eg the Helsinki Declaration
- Memberships, eg Climate Savers programme.
External stakeholder dialogue adds assurance by means of:
- Climate surveys, eg eVoice
- Open days
- Stakeholder consultations.
Community involvement adds assurance by means of:
- Investments in the community, eg World Diabetes Foundation, National Changing Diabetes Programmes, TakeAction! etc.
The governance structure and management systems which guide reporting in Novo Nordisk are described in the Corporate Governance section in About Novo Nordisk. A table containing all elements of the GRI Report Content by section and indicator can be found in the GRI Index.
See also
This page has been reviewed by PricewaterhouseCoopers as part of its assurance of Novo Nordisk’s non-financial reporting. Please refer to Audit and assurance for a full description of the conclusions and the nature of assurance offered.
